AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34406350 — intervention group
Group type: EXPERIMENTAL
Intervention: 2‐minute cryoballoon ablation
Number of subjects: 346
Study 35122877 — intervention group
Group type: EXPERIMENTAL
Intervention: 45-min moderate-intensity exercise
Number of subjects: 24
Study 35122877 — intervention group
Group type: COMPARATOR
Intervention: 60-min moderate-intensity exercise
Number of subjects: 24
Study 35122877 — intervention group
Group type: COMPARATOR
Intervention: Control session (55-min rest)
Number of subjects: 24
Study 34251873 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy with cisplatin (100 mg/m2) and docetaxel (85 mg/m2) followed by durvalumab (750 mg)
Number of subjects: 68
Study 34251873 — intervention group
Group type: COMPARATOR
Intervention: Neoadjuvant chemotherapy with cisplatin and docetaxel
Number of subjects: 68
Study 34251873 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy followed by durvalumab
Number of subjects: 68
Study 34143054 — intervention group
Group type: EXPERIMENTAL
Intervention: Proposed infrared image impulse-noise-suppression method using tensor robust principal component analysis and truncated total variation
Number of subjects: 0
Study 34143054 — intervention group
Group type: COMPARATOR
Intervention: State-of-the-art methods
Number of subjects: 0
Study 32436809 — intervention group
Group type: EXPERIMENTAL
Intervention: N-Butyl Cyanoacrylate (NBCA) sac embolization
Number of subjects: 44
Study 32436809 — intervention group
Group type: COMPARATOR
Intervention: EVAR without sac embolization (Control)
Number of subjects: 44
Study 34420205 — intervention group
Group type: EXPERIMENTAL
Intervention: Task-specific physiotherapist-led training
Number of subjects: 62
Study 34420205 — intervention group
Group type: COMPARATOR
Intervention: Parent-led home programme
Number of subjects: 62
Study 33129910 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemoradiation therapy (2 concurrent cycles of cisplatin followed by 4 cycles of carboplatin/paclitaxel)
Number of subjects: 660
Study 33129910 — intervention group
Group type: COMPARATOR
Intervention: Radiation therapy alone
Number of subjects: 660
Study 33129910 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemoradiation therapy
Number of subjects: 660
Study 33129910 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment groups
Number of subjects: 660
Study 33793460 — intervention group
Group type: EXPERIMENTAL
Intervention: mRNA BNT162b2 and mRNA-1273 COVID-19 vaccines (full immunization, ≥14 days after second dose)
Number of subjects: 3950
Study 33793460 — intervention group
Group type: EXPERIMENTAL
Intervention: mRNA BNT162b2 and mRNA-1273 COVID-19 vaccines (partial immunization, ≥14 days after first dose and before second dose)
Number of subjects: 3950
Study 33793460 — intervention group
Group type: COMPARATOR
Intervention: Unvaccinated participants
Number of subjects: 3950
Study 32876987 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey protein (30 g in 200 mL warm water at fasting time for 4 weeks)
Number of subjects: 50
Study 32876987 — intervention group
Group type: COMPARATOR
Intervention: Placebo (30 g in 200 mL warm water at fasting time for 4 weeks)
Number of subjects: 50
Study 36079822 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional supplements, diet education, and standard care
Number of subjects: 29
Study 36079822 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 29
Study 33354755 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist intervention involving medication therapy problem identification and recommendations
Number of subjects: 105
Study 33354755 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication therapy problems related to indication, effectiveness, and safety
Number of subjects: 105
Study 33354755 — intervention group
Group type: EXPERIMENTAL
Intervention: Recommendations from pharmacists
Number of subjects: 105
Study 32383544 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine learning algorithms (specifically gradient boosting algorithm)
Number of subjects: 16440
Study 32573121 — intervention group
Group type: EXPERIMENTAL
Intervention: Scleral buckling (SB)
Number of subjects: 58
Study 32573121 — intervention group
Group type: COMPARATOR
Intervention: Drainage–injection–pneumoretinopexy (DIP)
Number of subjects: 58
Study 32925516 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational video (n=11)
Number of subjects: 22
Study 32925516 — intervention group
Group type: COMPARATOR
Intervention: Control group (no video, n=11)
Number of subjects: 22
Study 35344567 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive paradigms of different complexities and durations (naming words beginning with P-, R-, V- and serial subtractions of 100–2, 100–7, 1000–17)
Number of subjects: 16
Study 35344567 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive paradigms of different complexities and durations
Number of subjects: 16
Study 34050594 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose losartan
Number of subjects: 100
Study 34050594 — intervention group
Group type: COMPARATOR
Intervention: Low-dose losartan
Number of subjects: 100
Study 35636444 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab plus FOLFOXIRI plus bevacizumab
Number of subjects: 218
Study 35636444 — intervention group
Group type: COMPARATOR
Intervention: FOLFOXIRI plus bevacizumab
Number of subjects: 218
Study 33797023 — intervention group
Group type: EXPERIMENTAL
Intervention: Abemaciclib plus fulvestrant
Number of subjects: 95
Study 33797023 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus fulvestrant
Number of subjects: 95
Study 32026625 — intervention group
Group type: EXPERIMENTAL
Intervention: Test Adhesive 1
Number of subjects: 23
Study 32026625 — intervention group
Group type: EXPERIMENTAL
Intervention: Test Adhesive 2
Number of subjects: 23
Study 32026625 — intervention group
Group type: EXPERIMENTAL
Intervention: Reference adhesive (PMV/MA-based)
Number of subjects: 23
Study 32026625 — intervention group
Group type: COMPARATOR
Intervention: No adhesive
Number of subjects: 23
Study 36222002 — intervention group
Group type: EXPERIMENTAL
Intervention: Perichondrium–cartilage island repair
Number of subjects: 84
Study 36222002 — intervention group
Group type: COMPARATOR
Intervention: TMF repair (Control)
Number of subjects: 84
Study 33966293 — intervention group
Group type: EXPERIMENTAL
Intervention: Cumulative melphalan exposure among cases (median 988 mg; IQR 644-1640)
Number of subjects: 26627
Study 33966293 — intervention group
Group type: COMPARATOR
Intervention: Cumulative melphalan exposure among controls (median 578 mg; IQR 360-967)
Number of subjects: 26627
Study 33966293 — intervention group
Group type: EXPERIMENTAL
Intervention: Median time to AML/MDS development
Number of subjects: 26627
Study 32248243 — intervention group
Group type: EXPERIMENTAL
Intervention: GAD-alum (20 μg, administered twice or three times)
Number of subjects: 0
Study 32248243 — intervention group
Group type: COMPARATOR
Intervention: Alum alone (control group)
Number of subjects: 0
Study 32248243 — intervention group
Group type: EXPERIMENTAL
Intervention: GAD-alum
Number of subjects: 0
Study 36737698 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg triamcinolone acetonide
Number of subjects: 84
Study 36737698 — intervention group
Group type: COMPARATOR
Intervention: 40 mg triamcinolone acetonide
Number of subjects: 84
Study 33735594 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferric carboxymaltose (Ferinject) 1,000 mg or 15 mg/kg if weight <66.7 kg
Number of subjects: 56
Study 33735594 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron dextran (Cosmofer) 20 mg iron/kg body weight
Number of subjects: 56
Study 33735594 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 56
Study 34305108 — intervention group
Group type: EXPERIMENTAL
Intervention: Independent physical activity programme for 2 months
Number of subjects: 106
Study 34305108 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 106
Study 32059954 — intervention group
Group type: EXPERIMENTAL
Intervention: All-inside quadrupled semitendinosus autograft (AIST)
Number of subjects: 64
Study 32059954 — intervention group
Group type: COMPARATOR
Intervention: Bone-patellar tendon-bone (BPTB)
Number of subjects: 64
Study 35873404 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg of ashwagandha root extract twice daily
Number of subjects: 50
Study 35873404 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 50
Study 32068472 — intervention group
Group type: EXPERIMENTAL
Intervention: Microneedling combined with PRP (4 sessions)
Number of subjects: 45
Study 32068472 — intervention group
Group type: EXPERIMENTAL
Intervention: Microneedling combined with PRP (6 sessions)
Number of subjects: 45
Study 32068472 — intervention group
Group type: COMPARATOR
Intervention: Fractional Er: YAG laser (4 sessions)
Number of subjects: 45
Study 32583313 — intervention group
Group type: EXPERIMENTAL
Intervention: Allisartan 240 mg/day and lifestyle modification
Number of subjects: 72
Study 32583313 — intervention group
Group type: COMPARATOR
Intervention: Lifestyle modification
Number of subjects: 72
Study 32583313 — intervention group
Group type: EXPERIMENTAL
Intervention: Allisartan
Number of subjects: 72
Study 36344008 — intervention group
Group type: EXPERIMENTAL
Intervention: eMOM GDM app with standard antenatal care
Number of subjects: 200
Study 36344008 — intervention group
Group type: COMPARATOR
Intervention: Standard antenatal care
Number of subjects: 200
Study 34602054 — intervention group
Group type: EXPERIMENTAL
Intervention: Mentoring support provided to OTs via phone or Microsoft Teams (88.6-100%), email, and SMS text messages.
Number of subjects: 41
Study 34602054 — intervention group
Group type: EXPERIMENTAL
Intervention: Mentoring support for OTs
Number of subjects: 41
Study 34602054 — intervention group
Group type: EXPERIMENTAL
Intervention: Mentoring as an implementation strategy
Number of subjects: 41
Study 34602054 — intervention group
Group type: EXPERIMENTAL
Intervention: Mentoring
Number of subjects: 41
Study 33589590 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine extended-release for 12 weeks
Number of subjects: 307
Study 33589590 — intervention group
Group type: EXPERIMENTAL
Intervention: Polygenic risk scores for cardioembolic stroke
Number of subjects: 307
Study 33646327 — intervention group
Group type: EXPERIMENTAL
Intervention: Response inhibition training
Number of subjects: 40
Study 33646327 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study 33000160 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 g oral l-histidine daily for 8 weeks
Number of subjects: 73
Study 33000160 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.8 g l-histidine daily for 12 weeks
Number of subjects: 73
Study 33000160 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study 33000160 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 g l-histidine daily
Number of subjects: 73
Study 35511938 — intervention group
Group type: EXPERIMENTAL
Intervention: Vopratelimab alone
Number of subjects: 201
Study 35511938 — intervention group
Group type: EXPERIMENTAL
Intervention: Vopratelimab with nivolumab
Number of subjects: 201
Study 35511938 — intervention group
Group type: EXPERIMENTAL
Intervention: Vopratelimab with ICOS-hi CD4 T-cells
Number of subjects: 201
Study 35511938 — intervention group
Group type: EXPERIMENTAL
Intervention: Potential genomic predictive biomarker
Number of subjects: 201
Study 35389028 — intervention group
Group type: COMPARATOR
Intervention: Triple combination cream alone (control group)
Number of subjects: 64
Study 35389028 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple combination cream + microneedling
Number of subjects: 64
Study 35389028 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple combination cream + tranexamic acid (TA 250 mg twice daily)
Number of subjects: 64
Study 35389028 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple combination cream + microneedling + tranexamic acid
Number of subjects: 64
Study 35944871 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan 40 mg
Number of subjects: 124
Study 35944871 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 124
Study 33675935 — intervention group
Group type: EXPERIMENTAL
Intervention: Reiki
Number of subjects: 42
Study 33675935 — intervention group
Group type: COMPARATOR
Intervention: Sham Reiki
Number of subjects: 42
Study 32854681 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischemic preconditioning (IPC) during surgery with preconditioning before aortic cross clamping (Arm 1)
Number of subjects: 110
Study 32854681 — intervention group
Group type: COMPARATOR
Intervention: Surgery without preconditioning before aortic cross clamping (Arm 2)
Number of subjects: 110
Study 34889723 — intervention group
Group type: EXPERIMENTAL
Intervention: Envisia Genomic Classifier
Number of subjects: 11
Study 36092537 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-volume split-dose regimen two (1.5L PEG after dinner, 0.75L PEG 4 hours before colonoscopy)
Number of subjects: 120
Study 36092537 — intervention group
Group type: COMPARATOR
Intervention: Low-volume split-dose regimen one (0.75L PEG after dinner, 1.5L PEG 4 hours before colonoscopy)
Number of subjects: 120
Study 34272327 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg/d
Number of subjects: 624
Study 34272327 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 624
Study 33190943 — intervention group
Group type: EXPERIMENTAL
Intervention: Contrast enhancement based adaptive denoising technique for speckle elimination and RPE layer extraction.
Number of subjects: 30
Study 33190943 — intervention group
Group type: EXPERIMENTAL
Intervention: Statistical approach for AMD/normal classification.
Number of subjects: 30
Study 33190943 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified RPE detection algorithm.
Number of subjects: 30
Study 33190943 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline estimation algorithm using randomization and polynomial fitting.
Number of subjects: 30
Study 32894785 — intervention group
Group type: EXPERIMENTAL
Intervention: Siltuximab (anti-IL-6 therapy)
Number of subjects: 79
Study 36396412 — intervention group
Group type: EXPERIMENTAL
Intervention: Reading 1 book a day (Group B)
Number of subjects: 52
Study 36396412 — intervention group
Group type: EXPERIMENTAL
Intervention: Reading 1 book a day and watching an infant brain development video (Group C)
Number of subjects: 52
Study 36396412 — intervention group
Group type: EXPERIMENTAL
Intervention: Always reading 7 books per week
Number of subjects: 52
Study 36396412 — intervention group
Group type: EXPERIMENTAL
Intervention: Instructing parents to read daily
Number of subjects: 52
Study 36396412 — intervention group
Group type: COMPARATOR
Intervention: No instructions (Group A)
Number of subjects: 52
Study 33626485 — intervention group
Group type: EXPERIMENTAL
Intervention: Music-based interventions (live or recorded music)
Number of subjects: 8
Study 32777163 — intervention group
Group type: EXPERIMENTAL
Intervention: Critical temperature (Tcrit) and initial response (m1) from segmented models
Number of subjects: 0
Study 32777163 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual scoring (stay-green) and chlorophyll fluorescence (ɸPSII) approaches
Number of subjects: 0
Study 32777163 — intervention group
Group type: EXPERIMENTAL
Intervention: Daytime respiration
Number of subjects: 0
Study 34100691 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrokinesiotherapy in a bucket for 10 minutes
Number of subjects: 34
Study 34100691 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) - only had the diaper changed
Number of subjects: 34
Study 33047176 — intervention group
Group type: EXPERIMENTAL
Intervention: PQ repair
Number of subjects: 80
Study 33047176 — intervention group
Group type: COMPARATOR
Intervention: No repair
Number of subjects: 80
Study 35960896 — intervention group
Group type: EXPERIMENTAL
Intervention: Gefitinib plus chemotherapy (GCP: gefitinib 250 mg orally once daily combined with carboplatin plus pemetrexed in a 3-week cycle for six cycles followed by concurrent gefitinib and pemetrexed maintenance)
Number of subjects: 0
Study 35960896 — intervention group
Group type: COMPARATOR
Intervention: Gefitinib (250 mg orally, once daily)
Number of subjects: 0
Study 35960896 — intervention group
Group type: EXPERIMENTAL
Intervention: Gefitinib plus chemotherapy (GCP)
Number of subjects: 0
Study 33793273 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual-oriented relationship education (PREP's Within My Reach curriculum)
Number of subjects: 322
Study 33793273 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 322
Study 33793273 — intervention group
Group type: EXPERIMENTAL
Intervention: All enrolled parents (treatment and control)
Number of subjects: 322
Study 32826010 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscle Energy Technique (MET)
Number of subjects: 20
Study 32826010 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical Diagnosis and Therapy (MDT)
Number of subjects: 20
Study 36075775 — intervention group
Group type: EXPERIMENTAL
Intervention: Rude response condition
Number of subjects: 125
Study 36075775 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological safety
Number of subjects: 125
Study 36075775 — intervention group
Group type: EXPERIMENTAL
Intervention: Across conditions
Number of subjects: 125
Study 34890350 — intervention group
Group type: EXPERIMENTAL
Intervention: TrendMD promotion for 6 months
Number of subjects: 3200
Study 34890350 — intervention group
Group type: COMPARATOR
Intervention: Control group (no promotion)
Number of subjects: 3200
Study 36271176 — intervention group
Group type: EXPERIMENTAL
Intervention: RT + TACE
Number of subjects: 120
Study 36271176 — intervention group
Group type: COMPARATOR
Intervention: TACE + RT
Number of subjects: 120
Study 32811749 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrative medicine visits
Number of subjects: 21
Study 32811749 — intervention group
Group type: COMPARATOR
Intervention: Standard medical visits
Number of subjects: 21
Study 32786325 — intervention group
Group type: EXPERIMENTAL
Intervention: Sparse measurements of library molecules using a machine learning algorithm to predict molecular function.
Number of subjects: 1012
Study 32786325 — intervention group
Group type: EXPERIMENTAL
Intervention: Amino acid sequences that bind weakly to a target.
Number of subjects: 1012
Study 35522848 — intervention group
Group type: EXPERIMENTAL
Intervention: Implicit racial bias measured using the child‐race implicit association test (IAT)
Number of subjects: 119
Study 35522848 — intervention group
Group type: EXPERIMENTAL
Intervention: Strong pro‐White implicit bias
Number of subjects: 119
Study 35522848 — intervention group
Group type: COMPARATOR
Intervention: Clinical decision making (opioid recommendations, management decisions, patient perceptions)
Number of subjects: 119
Study 32216594 — intervention group
Group type: EXPERIMENTAL
Intervention: Orange juice (pH = 3.5) with Phenobarbital (2.5 mg/kg)
Number of subjects: 40
Study 32216594 — intervention group
Group type: COMPARATOR
Intervention: Mineral water (neutral pH) with Phenobarbital (2.5 mg/kg)
Number of subjects: 40
Study 33217626 — intervention group
Group type: EXPERIMENTAL
Intervention: ASP-F≥25 mm (n=6; follicle aspiration 25-29 mm)
Number of subjects: 15
Study 33217626 — intervention group
Group type: EXPERIMENTAL
Intervention: ASP-F≥30 mm (n=6; follicle aspiration 30-34 mm)
Number of subjects: 15
Study 33217626 — intervention group
Group type: EXPERIMENTAL
Intervention: ASP-F≥35 mm (n=6; follicle aspiration 35-40 mm)
Number of subjects: 15
Study 33217626 — intervention group
Group type: EXPERIMENTAL
Intervention: ASP-F≥40 mm (n=6; follicle aspiration ≥40 mm)
Number of subjects: 15
Study 33217626 — intervention group
Group type: COMPARATOR
Intervention: Control (n=5; spontaneous ovulation or no follicle aspiration)
Number of subjects: 15
Study 32569700 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin
Number of subjects: 10142
Study 32569700 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10142
Study 34563243 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab biosimilar PF-06410293 (ADL-PF)
Number of subjects: 507
Study 34563243 — intervention group
Group type: EXPERIMENTAL
Intervention: Week 26 switch from reference adalimumab (ADL-EU) to ADL-PF
Number of subjects: 507
Study 34563243 — intervention group
Group type: EXPERIMENTAL
Intervention: Week 52 switch from ADL-EU to ADL-PF
Number of subjects: 507
Study 34563243 — intervention group
Group type: EXPERIMENTAL
Intervention: Week 26 switch from ADL-EU to ADL-PF
Number of subjects: 507
Study 33326877 — intervention group
Group type: EXPERIMENTAL
Intervention: EMR‐CDS
Number of subjects: 35
Study 33326877 — intervention group
Group type: EXPERIMENTAL
Intervention: EMR‐CDS + BHI‐CCM
Number of subjects: 35
Study 33326877 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 35
Study 32162727 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic floor and mobility exercises led by village paramedics
Number of subjects: 466
Study 32162727 — intervention group
Group type: EXPERIMENTAL
Intervention: Further 6-month exercise intervention led by village paramedics
Number of subjects: 466
Study 32162727 — intervention group
Group type: COMPARATOR
Intervention: Physiotherapy preceptors in the CRT
Number of subjects: 466
Study 35458200 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose kawakawa tea (4 g/250 mL water)
Number of subjects: 30
Study 35458200 — intervention group
Group type: COMPARATOR
Intervention: Water control
Number of subjects: 30
Study 33144226 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposomal bupivacaine (LB) interscalene nerve block (ISNB)
Number of subjects: 100
Study 33144226 — intervention group
Group type: COMPARATOR
Intervention: Standard bupivacaine ISNB (control)
Number of subjects: 100
Study 32533189 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically elevated SHBG
Number of subjects: 334977
Study 35007479 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Developmental Hypnotherapy (CDH)
Number of subjects: 40
Study 34882729 — intervention group
Group type: EXPERIMENTAL
Intervention: Medicine ball throws protocol (3 sets of 6 repetitions using a 2 kg ball, throwing at maximal speed)
Number of subjects: 10
Study 34882729 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training protocol (3 sets of 6 repetitions at 75% one-repetition maximum, lifting at maximal speed)
Number of subjects: 10
Study 33052500 — intervention group
Group type: EXPERIMENTAL
Intervention: Strong fixation preference (SFP) group (Group 1)
Number of subjects: 77
Study 33052500 — intervention group
Group type: COMPARATOR
Intervention: Alternating fixation group (Group 2)
Number of subjects: 77
Study 32557478 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypothermic machine perfusion (HMP)
Number of subjects: 0